Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2018 Filed Apr 2, 2018 16:05 UTC |
Palti YoramDirector · Chief Technology Officer
|
SaleOrdinary shares | 25,700 | $21.61 | $555,377.00 |
DisclosureSEC source: 0001209191-18-022352 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,405,354 F1 · price: On March 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 25,700 shares in multiple trades at prices ranging from $20.95 to $21.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| March 19, 2018 Filed Mar 20, 2018 16:37 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 49,728 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-18-020885 · doc4.xml · derivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 49,728 shares Expires 2019-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested and currently exercisable as of the date hereof. Read SEC document |
| March 19, 2018 Filed Mar 20, 2018 16:37 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 49,728 | $0.23 | $11,437.44 |
DisclosureSEC source: 0001209191-18-020885 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:22 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
GrantRestricted Stock Unit · Derivative | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015016 · doc4.xml · derivative · entry 2 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Ordinary Shares · 16,667 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:22 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
GrantOptions to Buy Ordinary Shares · Derivative | 121,655 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-015016 · doc4.xml · derivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,655 Underlying: Ordinary Shares · 121,655 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 121,655 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:21 UTC |
Kirson Eilon D.Chief Science Officer
|
GrantRestricted Stock Unit · Derivative | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015010 · doc4.xml · derivative · entry 2 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 Underlying: Ordinary Shares · 20,833 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:21 UTC |
Kirson Eilon D.Chief Science Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 152,068 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-015010 · doc4.xml · derivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,068 Underlying: Ordinary Shares · 152,068 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 152,068 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:14 UTC |
Ambrogi Michael J.Chief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 18,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014981 · doc4.xml · derivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,519 Underlying: Ordinary Shares · 18,519 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 16:14 UTC |
Ambrogi Michael J.Chief Operating Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 135,172 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-014981 · doc4.xml · derivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,172 Underlying: Ordinary Shares · 135,172 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 135,172 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:19 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 23,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015002 · doc4.xml · derivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,148 Underlying: Ordinary Shares · 23,148 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:19 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 168,965 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-015002 · doc4.xml · derivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,965 Underlying: Ordinary Shares · 168,965 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 168,965 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:18 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
GrantRestricted Stock Unit · Derivative | 27,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014994 · doc4.xml · derivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,778 Underlying: Ordinary Shares · 27,778 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:18 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
GrantOptions to Buy Ordinary Shares · Derivative | 202,758 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-014994 · doc4.xml · derivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,758 Underlying: Ordinary Shares · 202,758 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 202,758 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:16 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 27,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014987 · doc4.xml · derivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,778 Underlying: Ordinary Shares · 27,778 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. F3 · derivative.expiration_date: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:16 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 202,758 | $0.00 Strike: $21.15 | $0.00 |
DisclosureSEC source: 0001209191-18-014987 · doc4.xml · derivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,758 Underlying: Ordinary Shares · 202,758 shares Expires 2028-02-27 F1 · derivative.exercise_date: Options to buy 202,758 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 17:14 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 6,591 | $19.83 | $130,686.35 |
DisclosureSEC source: 0001209191-18-013433 · doc4.xml · nonDerivative · entry 2 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,074 F1 · price: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 17:13 UTC |
Ambrogi Michael J.Chief Operating Officer
|
SaleOrdinary Shares | 8,458 | $19.83 | $167,705.22 |
DisclosureSEC source: 0001209191-18-013430 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,830 F1 · price: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 22:09 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 13,351 | $19.83 | $264,723.63 |
DisclosureSEC source: 0001209191-18-013422 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,061 F1 · price: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale is mandated by the Issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:14 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 21,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013433 · doc4.xml · derivative · entry 3 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,333 Underlying: Ordinary Shares · 21,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:14 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
Exercise / conversionOrdinary Shares | 21,667 | $21.55 | $466,923.85 |
DisclosureSEC source: 0001209191-18-013433 · doc4.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:13 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 31,201 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013430 · doc4.xml · derivative · entry 3 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,399 Underlying: Ordinary Shares · 31,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:13 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 31,201 | $21.55 | $672,381.55 |
DisclosureSEC source: 0001209191-18-013430 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:10 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 36,401 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013425 · doc4.xml · derivative · entry 2 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,799 Underlying: Ordinary Shares · 36,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 17:10 UTC |
Kirson Eilon D.Chief Science Officer
|
Exercise / conversionOrdinary Shares | 36,401 | $21.55 | $784,441.55 |
DisclosureSEC source: 0001209191-18-013425 · doc4.xml · nonDerivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:11 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 53,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013427 · doc4.xml · derivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,666 Underlying: Ordinary Shares · 53,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:11 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 53,334 | $21.55 | $1,149,347.70 |
DisclosureSEC source: 0001209191-18-013427 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:09 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 43,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013422 · doc4.xml · derivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,666 Underlying: Ordinary Shares · 43,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 22:09 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
Exercise / conversionOrdinary Shares | 43,334 | $21.55 | $933,847.70 |
DisclosureSEC source: 0001209191-18-013422 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 16:14 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 50,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-18-008432 · doc4.xml · derivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,087 Underlying: Ordinary Shares · 50,000 shares Expires 2019-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested and currently exercisable as of the date hereof. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 16:14 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 50,000 | $0.23 | $11,500.00 |
DisclosureSEC source: 0001209191-18-008432 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 16:29 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 11,630 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001209191-18-006215 · doc4.xml · derivative · entry 3 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,152 Underlying: Ordinary Shares · 82,782 shares Expires 2022-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested and exercisable as of the date hereof. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 16:29 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 11,630 | $24.00 | $279,120.00 |
DisclosureSEC source: 0001209191-18-006215 · doc4.xml · nonDerivative · entry 2 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,998 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 16:29 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
Exercise / conversionOrdinary Shares | 11,630 | $6.72 | $78,153.60 |
DisclosureSEC source: 0001209191-18-006215 · doc4.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 21:22 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 13,974 | $24.02 | $335,588.40 |
DisclosureSEC source: 0001209191-18-006207 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,790 F1 · shares: On January 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 13,974 shares in multiple trades at prices ranging from $24.00 to $24.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 25, 2018 Filed Jan 26, 2018 21:14 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 6,456 | $22.43 | $144,839.71 |
DisclosureSEC source: 0001209191-18-005555 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,764 F1 · shares: On January 25, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 6,456 shares in multiple trades at prices ranging from $22.00 to $22.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 21:26 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 10,600 | $22.17 | $235,007.30 |
DisclosureSEC source: 0001209191-18-005377 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,220 F2 · shares: On January 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,600 shares in multiple trades at prices ranging from $22.00 to $22.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:26 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 10,248 | $22.03 | $225,794.18 |
DisclosureSEC source: 0001209191-18-005377 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,820 F1 · shares: On January 23, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,248 shares in multiple trades at prices ranging from $22.00 to $22.15. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:18 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Exercise / conversionWarrants · Derivative | 1,549 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001209191-18-005099 · doc4.xml · derivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,549 shares Expires 2018-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable at any time through January 22, 2018 Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:18 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
Exercise / conversionOrdinary Shares | 1,549 | $3.59 | $5,560.91 |
DisclosureSEC source: 0001209191-18-005099 · doc4.xml · nonDerivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 22:05 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 14,900 | $22.20 | $330,754.67 |
DisclosureSEC source: 0001209191-18-004010 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,068 F1 · price: On January 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 14,900 shares in multiple trades at prices ranging from $22.00 to $22.50. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:00 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 22,895 | $22.02 | $504,237.19 |
DisclosureSEC source: 0001209191-18-003626 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,968 F2 · price: On January 12, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 22,895 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 17:01 UTC |
Kirson Eilon D.Chief Science Officer
|
SaleOrdinary Shares | 25,320 | $22.00 | $557,126.09 |
DisclosureSEC source: 0001209191-18-003629 · doc4.xml · nonDerivative · entry 1 Kirson Eilon D. · CIK 0001654356 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,181 F1 · price: On January 11, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 25,320 shares in multiple trades at prices ranging from $22.00 to $22.10. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 22:00 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 313,525 | $22.35 | $7,007,503.22 |
DisclosureSEC source: 0001209191-18-003626 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,863 F1 · price: On January 11, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 313,525 shares in multiple trades at prices ranging from $22.00 to $22.85. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 09, 2018 Filed Jan 10, 2018 21:11 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 31,132 | $21.02 | $654,375.96 |
DisclosureSEC source: 0001209191-18-003113 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,078 F3 · price: On January 9, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 31,132 shares in multiple trades at prices ranging from $21.00 to $21.05. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 16:09 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
GrantOrdinary Shares | 166 | $15.05 | $2,497.47 |
DisclosureSEC source: 0001209191-18-003112 · doc4.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,998 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2017 through December 31, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 3, 2017. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 21:11 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
GrantOrdinary Shares | 310 | $15.05 | $4,663.95 |
DisclosureSEC source: 0001209191-18-003113 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,210 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2017 through December 31, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 3, 2017. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 21:06 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantOrdinary Shares | 283 | $15.05 | $4,257.74 |
DisclosureSEC source: 0001209191-18-003111 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,388 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2017 through December 31, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 3, 2017. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 21:06 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 26,264 | $21.03 | $552,313.54 |
DisclosureSEC source: 0001209191-18-002436 · doc4.xml · nonDerivative · entry 3 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,900 F2 · price: On January 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 26,264 shares in multiple trades at prices ranging from $21.00 to $21.075. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:06 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 2,404 | $21.00 | $50,484.00 |
DisclosureSEC source: 0001209191-18-002436 · doc4.xml · nonDerivative · entry 2 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,164 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:06 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
SaleOrdinary Shares | 200 | $21.03 | $4,205.00 |
DisclosureSEC source: 0001209191-18-002436 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,568 F1 · shares: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.